WI
RDY icon

WBI Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

WBI Investments’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-51,340
Closed -$540K – 231
2014
Q3 		$540K Buy
+51,340
New +$483K 0.02% 148

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $9.24B AUM 21.27% 1-Year Est. Return

WBI Investments's RDY Position: Q4 2014 in Review

WBI Investments sold out of Dr. Reddy's Laboratories (RDY) in Q4 2014, closing a stake of 51,340 shares — an estimated $540K sold.

WBI Investments first reported a position in RDY in Q3 2014 and held it in 1 quarter. The position peaked at $540K in Q3 2014. 168 funds tracked by Wall St. Rank hold RDY as of Q4 2014.

  • WBI Investments reported no remaining Dr. Reddy's Laboratories position as of Q4 2014 after selling out during the quarter.
  • WBI Investments sold 51,340 Dr. Reddy's Laboratories shares in Q4 2014, an estimated $540K.
  • WBI Investments first reported a position in Dr. Reddy's Laboratories in Q3 2014 and held it in 1 quarter.
  • WBI Investments's Dr. Reddy's Laboratories position peaked at $540K in Q3 2014.
  • 168 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2014.

Based on WBI Investments's 13F filing for Q4 2014, filed 12 Feb 2015.